Article
Genetically informed lung cancer medicine.
The Journal of pathology - 1 Jan 2011
Pao William, Iafrate A John, Su Zengliu
Abstract excerpt
Knowledge of tumour mutation status has become increasingly important for the prioritization of targeted therapies for cancer. We review here the major known 'driver' mutations with therapeutic relevance in non-small cell lung cancer. We also discuss a variety of methods now being employed in molecular diagnostic laboratories to detect genetic alterations in lung tumours. A genetically-informed approach to lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
